Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition

Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition

US Patent 8138174 · Granted Mar 20, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synthesis of substituted pyrazoline carboxamidine derivatives2016
Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists2015
1H-imidazole derivatives as cannabinoid CB2 receptor modulators2015
Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists2014
Heterocyclic compounds with affinity to muscarinic receptors2014
1H-imidazole derivative having CB1, agonistic, CB1 partial agonistic or CB1 anta2014
1H-imidazole derivative having CB1, agonistic, CB1 partial agonistic or CB1 anta2014
Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HT6 antag2014
Heterocyclic compounds with affinity to muscarinic receptors2013
Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers2013
Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists2013
Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor a2013